The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review
Guardado en:
Autores principales: | Shauna McKibben, Andy Bush, Mike Thomas, Chris Griffiths |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74a34e16d8404c9ca1ae08e493eab18b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
por: Cheng-Yi Wang, et al.
Publicado: (2021) -
Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: A. Marques
Publicado: (2021) -
Influence of the first wave of COVID-19 on asthma inhaler prescriptions
por: C. I. Bloom, et al.
Publicado: (2021) -
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
por: Ian D. Pavord, et al.
Publicado: (2017) -
Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
por: Janine Pilcher, et al.
Publicado: (2017)